RxDoctor Payments Data

Sandra Mitkos

Family · Potosi, MONPI 1790015527

Payments from drug & device makers

$1,987in general payments, 2019–2025

Across 93 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$429
  • Lilly USA, LLC$235
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$201
  • Novo Nordisk$188
  • Nevro Corp.$172
  • Teva Pharmaceuticals USA, Inc.$139
  • plus $624 from 19 others

What the payments were for

  • Food & beverage$1,987100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,987 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$33,751
TrulicityDulaglutide24$31,526
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$29,441
JardianceEmpagliflozin15$10,505
EliquisApixaban15$8,498
Albuterol Sulfate HfaAlbuterol Sulfate141$4,294
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$2,967
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,988
Omeprazole110$1,236
Potassium Chloride123$864
Levothyroxine Sodium126$820
Gabapentin73$645
Atorvastatin Calcium141$638
Cefdinir32$615
Ventolin HfaAlbuterol Sulfate11$602

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$188$33,75127 claims
Lilly USA, LLCTrulicity$235$31,52624 claims
GSKTrelegy Ellipta$69$29,44143 claims
Boehringer IngelheimJardiance$17$10,50515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Potosi

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →